Prestige Wealth Management Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-450
| Closed | -$2K | – | 1068 |
|
|
2021
Q2 | $2K | Hold |
450
| – | – | ﹤0.01% | 842 |
|
|
2021
Q1 | $2K | Hold |
450
| – | – | ﹤0.01% | 839 |
|
|
2020
Q4 | $1K | Hold |
450
| – | – | ﹤0.01% | 915 |
|
|
2020
Q3 | $1K | Sell |
450
-4,000
| -90% | -$8.89K | ﹤0.01% | 860 |
|
|
2020
Q2 | $15K | Buy |
4,450
+450
| +11% | +$1.52K | 0.01% | 378 |
|
|
2020
Q1 | $15K | Hold |
4,000
| – | – | 0.01% | 327 |
|
|
2019
Q4 | $24K | Hold |
4,000
| – | – | 0.01% | 269 |
|
|
2019
Q3 | $30K | Hold |
4,000
| – | – | 0.02% | 237 |
|
|
2019
Q2 | $54K | Buy |
+4,000
| New | +$54K | 0.03% | 191 |
|